Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-01-23 Coulie Bernard President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2021-01-23 Cummings Keith Lamont Chief Financial Officer Grant or award · Stock Option (right to buy) +74,250 74,250
2021-01-23 Lefebvre Eric Chief Medical Officer Grant or award · Stock Option (right to buy) +73,250 73,250
2021-01-23 Hull Hans Chief Business Officer Grant or award · Stock Option (right to buy) +62,250 62,250
2021-01-23 Ouimette Mike General Counsel & Corp. Sec'y Grant or award · Stock Option (right to buy) +15,520 15,520
2021-01-14 Coulie Bernard President and CEO Sale −2,870 $26.20 $75K 467,947
2021-01-14 Coulie Bernard President and CEO Sale −630 $27.21 $17K 467,317
2021-01-12 PYOTT DAVID E I Director Grant or award · Stock Option (right to buy) +26,573 26,573
2020-12-30 Hull Hans Chief Business Officer Exercise or conversion +3,500 $2.08 $7K 120,746
2020-12-30 Hull Hans Chief Business Officer Exercise or conversion · Stock Option (right to buy) −3,500 17,479
2020-12-21 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +4,500 $2.08 $9K 27,621
2020-12-21 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −4,500 190,097
2020-12-18 Lefebvre Eric Chief Medical Officer Sale −6,788 $26.17 $178K 167,792
2020-12-18 Lefebvre Eric Chief Medical Officer Sale −5,712 $26.98 $154K 162,080
2020-12-14 Coulie Bernard President and CEO Sale −3,163 $27.32 $86K 471,154
2020-12-14 Coulie Bernard President and CEO Sale −337 $27.86 $9K 470,817
2020-12-01 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +11,591 $2.08 $24K 34,712
2020-12-01 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +7,143 $6.22 $44K 41,855
2020-12-01 Cummings Keith Lamont Chief Financial Officer Sale −1,139 $28.24 $32K 40,716
2020-12-01 Cummings Keith Lamont Chief Financial Officer Sale −1,848 $29.07 $54K 38,868

Page 17 of 19 · 379 trades